DurgicalDurgical
EN
Open the app

Dipyridamole !

An oral antiplatelet and vasodilator that raises adenosine around platelets. It is combined with warfarin after heart valve replacement.

Updated 2026-11-01

  • Class: Antiplatelet drugs
  • Transporter: Equilibrative nucleoside transporter 1 (adenosine uptake), and phosphodiesterases
  • ATC code: B01AC07

Mechanism of action

Dipyridamole blocks the uptake of adenosine into platelets, endothelial cells and red blood cells. The extra adenosine acts on platelet A2 receptors, which raise cAMP through adenylate cyclase and make platelets less responsive to ADP, collagen and platelet-activating factor. It also inhibits phosphodiesterases, especially the one that breaks down cGMP, which adds to the effect of nitric oxide and dilates vessels.

  1. Dipyridamole blocks adenosine uptake into cells
  2. Adenosine acts on platelet A2 receptors and raises cAMP
  3. Phosphodiesterase inhibition adds cGMP: platelets calm, vessels dilate

Pharmacokinetics

Absorption
By mouth; peak levels about 75 minutes after a dose.
Distribution
Highly bound to plasma proteins.
Metabolism
In the liver, conjugated to a glucuronide.
Elimination
In the bile.
Half-life
Terminal half-life about 10 hours.

Indications

  • Together with warfarin, to prevent thromboembolic complications after heart valve replacement.

Adverse effects

Common

  • Dizziness
  • Abdominal discomfort, diarrhoea, vomiting
  • Headache, flushing
  • Rash and itching

Contraindications

  • Hypersensitivity to dipyridamole

Key interactions

Adenosine and regadenoson (stress testing)
Their levels and cardiovascular effects increase; dipyridamole tablets are paused before the test.
Cholinesterase inhibitors
Their effect may be opposed, which can worsen myasthenia gravis.
Warfarin and other anticoagulants or antiplatelets
Add to bleeding risk.

What is monitored

  • Blood pressure, especially at the start
  • Chest pain in patients with coronary disease
  • Liver enzymes
  • INR, as warfarin is given together

Administration and safety

  • Oral, as an add-on to warfarin after valve replacement
  • Tablets are paused before pharmacological stress testing with adenosine, regadenoson or intravenous dipyridamole
  • A fixed combination of aspirin with extended-release dipyridamole also exists; it is a different product

Nursing care

  • Check blood pressure and ask about chest pain before and after starting
  • Warn that dizziness and headache are common at first and often settle
  • Make sure the cardiology or nuclear medicine team knows about it before a stress test
  • Watch for bleeding signs together with the INR

Pregnancy and breastfeeding

Animal studies did not show harm, but human data are limited; it is used only if clearly needed.

Test yourself

Think of the answer, then tap the question to see it.

How does dipyridamole inhibit platelets?

It blocks adenosine uptake; the extra adenosine acts on platelet A2 receptors and raises cAMP. It also inhibits phosphodiesterases, especially the cGMP one.

Why is dipyridamole paused before an adenosine or regadenoson stress test?

It increases the levels and cardiovascular effects of adenosine and regadenoson, raising the risk of side effects and reducing test sensitivity.

With which drug is dipyridamole tablet therapy combined after valve replacement?

With warfarin (a coumarin anticoagulant).

Add to my cards (3)

← Back to the class: Antiplatelet drugs

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - DIPYRIDAMOLE tablet, film coated (DailyMed (U.S. National Library of Medicine), 2026); Dipyridamole: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.